Vol. 2 No. 14: Immunomodulatory drugs: the foundation for treating hematological malignancies Amsterdam, 15 June 2006 | Hematology Meeting Reports (formerly Haematologica Reports)

Current Issue

Vol. 2 No. 14

10 June 2009

View this Issue

Vol. 2 No. 14: Immunomodulatory drugs: the foundation for treating hematological malignancies Amsterdam, 15 June 2006

Published: 10 June 2009

Articles

Introduction

Meletios Dimopoulos

https://doi.org/10.4081/hmr.v2i14.507

155

PDF: 113
- PDF
Improving treatment outcomes by understanding cytogenetics in myelodysplastic

Aristotle Giagounidis

https://doi.org/10.4081/hmr.v2i14.508

177

PDF: 336
- PDF
Transfusion independence and cytogenetic response in myelodysplastic syndromes. What this means for the patient

Alan F. List

https://doi.org/10.4081/hmr.v2i14.509

194

PDF: 532
- PDF
Prolonging time to progression and survival in relapsed/refractory multiple myeloma

Pieter Sonneveld

https://doi.org/10.4081/hmr.v2i14.510

207

PDF: 405
- PDF
Targeting the microenvironment: a new treatment paradigm for chronic lymphocytic leukaemia

Asher Chanan-Khan

https://doi.org/10.4081/hmr.v2i14.511

176

PDF: 456
- PDF

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy